Controversies in the treatment of Burkitt lymphoma in AIDS Journal Article


Author: Noy, A.
Article Title: Controversies in the treatment of Burkitt lymphoma in AIDS
Abstract: Purpose of review: The success of combined antiretroviral therapy (cART) has transformed HIV infection into a survivable chronic disease in developed countries. Increasingly then, the risks of HIV associated cancers become paramount. Burkitt lymphoma is one of the cancer subtypes highly disproportionately affecting HIV infected patients. Recent findings: Recent conference proceedings appear to corroborate early reports that intensive therapy of HIV-Burkitt lymphoma is feasible and effective. An optimal approach is not defined due to the small numbers of patients in current trials and the absence of comparison studies. Moreover, as breakthroughs in the pathogenesis of lymphoma in general and Burkitt lymphoma in particular suggest that HIV infection plays a significant role, the opportunity for targeted therapy based on differences in biology are wholly untapped. Summary: Advances are being made in HIV-Burkitt lymphoma, but future studies need to incorporate our expanding understanding of biology to improve efficacy and reduce toxicity, preferably by integrating a biologic approach to this curable disease. © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Keywords: cancer chemotherapy; treatment outcome; unclassified drug; prednisone; clinical trial; pathogenesis; review; doxorubicin; cancer risk; nonhuman; clinical trials as topic; comparative study; cytarabine; methotrexate; rituximab; disease association; etoposide; antineoplastic combined chemotherapy protocols; cyclophosphamide; vincristine; ifosfamide; intensive care; multicenter study; folinic acid; lymphoma; comorbidity; acquired immune deficiency syndrome; acquired immunodeficiency syndrome; clinical effectiveness; recombinant granulocyte colony stimulating factor; lymphoma, aids-related; burkitt lymphoma; hiv; virotherapy; africa; aids; burkitt; mensa; anti-retroviral agents
Journal Title: Current Opinion in Oncology
Volume: 22
Issue: 5
ISSN: 1040-8746
Publisher: Lippincott Williams & Wilkins  
Date Published: 2010-09-01
Start Page: 443
End Page: 448
Language: English
DOI: 10.1097/CCO.0b013e32833d7dbe
PUBMED: 20683266
PROVIDER: scopus
PMCID: PMC3415038
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: CUOOE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy
Related MSK Work